| Name | Title | Contact Details |
|---|
The Badminton World Federation (BWF) is the international governing body of the sport of badminton, recognised by the International Olympic Committee (IOC) and the International Paralympic Committee (IPC). It was originally the International Badminton Federation (IBF) which was founded on 5 July, 1934, before being rechristened the Badminton World Federation in 2006. The purpose and objectives of BWF include regulating, promoting, developing and popularising the sport of badminton throughout the world and organising, conducting and presenting international events at the highest level. The BWFs vision is to make badminton a leading global sport accessible to all – giving every child a chance to play for life. Its mission is to lead and inspire all stakeholders; to deliver entertainment through exciting events to drive fan experience; and to create innovative, impactful and sustainable development initiatives. BWF has its headquarters in Kuala Lumpur, Malaysia, with 194 Member Associations worldwide. Poul-Erik Høyer is the BWF President and Thomas Lund is the BWF Secretary General.
F1® returns to the Las Vegas Strip November 21-23, 2024!
FABCON Design and Engineering (Pvt.) Ltd. is a multidisciplinary EPC Management Company, engaged in engineering, manufacturing and construction in the field of civil, mechanical, electrical and automation projects. Our primarily serving industries includes; • Oil and Gas Exploration • Refineries • Petrochemicals • OMC Plants • LPG Plants • Power Plants • Fertilizers Industry • Cement Industry • Sugar Industry • Textile Industry • Food and Beverages Industry • Paper and Pulp Industry • Commercial Infrastructure Projects • Government Infrastructure Development Sector • Defence Infrastructure Development Sector
ABB is a technology leader in electrification and automation, enabling a more sustainable and resource-efficient future. The companys solutions connect engineering know-how and software to optimize how things are manufactured, moved, powered and operated. Building on over 140 years of excellence, ABBs more than 105,000 employees are committed to driving innovations that accelerate industrial transformation. www.abb.com Privacy notice & house rules: https://social.abb/social-media-information Before applying for a job at ABB, please read our Fraud Warning: https://careers.abb/global/en/fraud-warning
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.